Company Filing History:
Years Active: 2019-2024
Title: Michael Dawson: Innovator in Polymyxin Compounds
Introduction
Michael Dawson is a notable inventor based in Reading, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of polymyxin compounds. With a total of 3 patents to his name, Dawson's work focuses on innovative methods for treating bacterial infections.
Latest Patents
Dawson's latest patents include groundbreaking inventions related to polymyxin compounds. One of his notable patents, titled "Polymyxin compounds and uses thereof," provides a compound of formula (I) and its application in treatment methods for bacterial infections. This invention outlines the preparation methods for the compound and specifies the structural requirements for the amino acid residues involved. Another patent in this area emphasizes the pharmaceutical compositions comprising these compounds and their use in treating microbial infections.
Career Highlights
Throughout his career, Michael Dawson has worked with several prominent companies in the pharmaceutical industry. Notable among these are Spero Therapeutics, Inc. and New Pharma Licence Holdings Limited. His work in these organizations has contributed to advancements in medical treatments and drug development.
Collaborations
Dawson has collaborated with various professionals in his field, including Pamela Brown and Mona Simonovic. These partnerships have facilitated the exchange of ideas and fostered innovation in his research endeavors.
Conclusion
Michael Dawson's contributions to the field of polymyxin compounds highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical treatments for bacterial infections.